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Abstract: A genome-scale metabolic model of the Gram-
positive, facultative anaerobic opportunistic pathogen
Staphylococcus aureus N315 was constructed based on
current genomic data, literature, and physiological infor-
mation. The model comprises 774 metabolic processes
representing approximately 23% of all protein-coding
regions. The model was extensively validated against
experimental observations and it correctly predictedmain
physiological properties of the wild-type strain, such as
aerobic and anaerobic respiration and fermentation. Due
to the frequent involvement of S. aureus in hospital-
acquired bacterial infections combinedwith its increasing
antibiotic resistance, we also investigated the clinically
relevant phenotype of small colony variants and found
that the model predictions agreed with recent findings of
proteome analyses. This indicates that themodel is useful
in assisting future experiments to elucidate the interrela-
tionship of bacterial metabolism and resistance. To help
directing future studies for novel chemotherapeutic
targets, we conducted a large-scale in silico gene deletion
study that identified 158 essential intracellular reactions.
A more detailed analysis showed that the biosynthesis of
glycans and lipids is rather rigid with respect to circum-
venting gene deletions, which should make these areas
particularly interesting for antibiotic development. The
combination of this stoichiometric model with trans-
criptomic and proteomic data should allow a new quality
in the analysis of clinically relevant organisms and a
more rationalized system-level search for novel drug
targets.  2005 Wiley Periodicals, Inc.
Keywords: Staphylococcus aureus; genome-scale meta-
bolic network; gene deletion; small colony variant
INTRODUCTION
Most staphylococci, Gram-positive natural habitants of skin
and mucous membranes of humans, are opportunistic
pathogens and are the most frequent cause for community-
acquired and nosocomial infections (Novick, 2003). Their
formidable ability to rapidly acquire antibiotic resistance
often poses therapeutic problems. Especially Staphylococcus
aureus, a coagulase-positive bacterium, has become a major
public health threat as a result of the increased incidence of its
drug resistance from penicillin/methicillin—via quinolone—
to vancomycin resistance (Witte, 1999).
Various approaches are currently pursued to understand
the origin of its antibiotic resistance (Lowy, 2003). Now, that
the genomic sequence of this organism (Kuroda et al.,
2001) as well as extensive proteomic (Cordwell et al., 2002;
Hecker et al., 2003) and transcriptional data (Dunman et al.,
2004; Kuroda et al., 2003) are available, it is hoped that a
more holistic understanding will be achieved, consequently
allowing a better identification of new drug targets.
The ultimate goal of acquiring ‘‘-omics’’ information is to
develop a system-scale model that would allow rationally
collapsing the huge amount of experimental information into
a manageable (mathematical) model and thus help creating
knowledge from data. This knowledge can then be used to
explain a strain’s physiology or to predict physiology in
various real situations, particularly such that are difficult to
access experimentally (such as in vivo experiments involving
infections). As such an in silico model of a microorganism
can be executed in minutes, it is possible to evaluate large sets
of hypotheses for principle feasibility in advance, thus
reducing laborious experimental series to a minimum.
En route towards a systems level model of microorgan-
isms, genome-scale metabolic models are typically devel-
oped as a first step. Such models now exist for species such as
E. coli (Reed et al., 2003), S. cereviseae (Fo¨rster et al., 2003),
or H. pylori (Schilling et al., 2002). They exploit the vast
experimental work that has been done to elucidate many
aspects of organisms’ metabolism, organize the information
into a set of reaction equations, and thus, for example, allow
appreciating the effect of deletions or additional reactions in
the context of the complete (known) metabolism.
Besides representing organism-specific comprehensive
metabolic compendia, stoichiometric models constitute the
very basis of any in silico model describing entire cellular
function (Patil et al., 2004). It was shown that already from
these models—capturing only one aspect of microbial
physiology—fundamental metabolic capabilities could be
deduced (Price et al., 2003) and even regulatory principles
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could be identified (Stelling et al., 2002) by means of
constraint-based modeling or pathway analysis (Papin et al.,
2004). In combination with gene expression data or by
addition of regulatory information (resulting in the addition
or removal of pathways from the set of equations, for
example through Boolean operators), the predictive power of
such metabolic models can even be further enhanced
(Akesson et al., 2004; Covert et al., 2004).
In addition, for pathogenic microorganisms, such a model
might be useful in investigating the relationship between
microbial metabolism and phenotypes that are clinically
relevant and ultimately suggesting ways to exploit this
knowledge in therapy. For example, a main thrust of current
S. aureus research is concerned with mechanisms of
antibiotic resistance and regulatory aspects of pathogenicity
and virulence (Bronner et al., 2004; Novick, 2003; Witte,
1999). Several findings indicate that metabolic factors might
play a significant role in antibiotic resistance and in the
expression of virulence factors. For instance, the character-
istic phenotype of small colony variants (SCV) is of high
clinical relevance because it leads to particularly resistant
pathogens. It is defined by a reduced growth rate and an
altered pattern in carbohydrate utilization (Kohler et al.,
2003; McNamara and Proctor, 2000) and thus illustrates the
importance of the relationship between bacterial metabolism
and the expression of virulence factors. Similarly, Somerville
and co-workers stressed the importance of tricarboxylic acid
(TCA) cycle activity and acetate metabolism in the context of
virulence factor production (Somerville et al., 2002, 2003).
Furthermore, resistance to vancomycin involves a reorgani-
zation of cell wall metabolism leading to a grossly thickened
cell wall with reduced peptidoglycan cross-linking (Lowy,
2003). The redirected carbon flux towards cell wall synthesis
observed in Mu50 and VM50 strains (Hanaki et al., 1998;
Sieradzki and Tomasz, 1999) underlines that metabolic
factors should also be taken into account when studying
antibiotic resistance.
As a first step towards the systematic evaluation of
metabolic factors in S. aureus research, we have developed
a genome-scale metabolic model for S. aureus, more
specifically using genomic information for the methicillin-
resistant (MRSA) strain N315. We made use of annotations
from different genomic databases, defined the biomass
composition from biochemical literature, and added missing
functions in order to complete specific pathways leading to
certain biomass components and to represent physiological
behavior. This model was validated by comparing its results to
an as comprehensive set of experimental data as possible. This
validated model in turn could then reproduce main physio-
logical aspects, including for example the behavior of small
colony variants, suggesting that indeed such models are useful
in analyzing specific, clinically important properties. The
reproductions could be further confirmed by recent expres-
sion data from the literature. Finally, we used the model to
systematically search for essential genes in the S. aureus
genome in order to guide future activities in the development
of novel chemotherapeutics against essential gene products.
MATERIALS AND METHODS
Stochiometric Models and Flux Balance Analysis
A stoichiometric model is derived from mass balances for
each metabolite in an organism’s reaction network. At steady
state, this system of mass balance equations is represented as
S  v¼ b, where S is the stoichiometric matrix with the
stoichiometric coefﬁcients of all the metabolites in all
intracellular and transport reactions, v is the ﬂux vector
containing all reaction rates vi, and vector b represents the
ﬂuxes of metabolites exchanged with the environment
(i.e., the substrate uptake rates, by-product production rates).
Exchange fluxes are zero for all internal metabolites, which
cannot be transported across the cell membrane. Details of the
procedure have been described (Stephanopoulos et al., 1998).
In addition to the mass balance equations, metabolic
models generally also include constraint equations, which
assign a direction to an in principle reversible metabolic
reaction according to known thermodynamic constraints.
These equations have the form ai  vi  bi, where ai and bi
are the feasible lower and upper limits of the reaction rate ni,
respectively. For irreversible reactions, ai is set to zero and
for reversible reactions both values are typically set to
arbitrarily large values. Besides defining the directions of all
metabolic reactions, these constraints can also be used to
specify a maximum flux through a given reaction (e.g.,
resulting from a limited amount of an enzyme), or to specify a
measured substrate uptake rate, to include the knowledge of
the minimum flux through a certain metabolic reaction, or to
restrict the flux through certain reactions due to regulatory
events occurring within the cell (i.e., repression of certain
enzymes).
A solution of the system of mass balance equations is
called a flux distribution and identifies the reaction rates in a
cell with which metabolic reactions occur. However, despite
the introduction of constraints and some pre-set fluxes
(e.g., substrate uptake rates), the number of unknown fluxes is
typically still greater than the number of mass balance
equations, which leaves the system of mass balances
underdetermined. Consequently, there exists a set of possible
solutions (flux distributions) that can satisfy the model
equations. To identify a particular flux distribution within the
large set of possible solutions, linear programming optimiza-
tion can be used to maximize a certain metabolic objective,
implicitly assuming that the cell follows this specific
rationale when selecting the particular metabolic routes that
comprise bacterial metabolism under the given environ-
mental conditions. This approach is referred to as flux
balance analysis (FBA) (Varma et al., 1993). For our work,
we have utilized maximization of biomass production as
objective function. For solving the optimization problem, we
employed the commercial software package LINDO (Lindo
Systems, Chicago, IL) coupled to MATLAB (Mathworks,
Natick, MA).
For in silico modeling experiments, also a growth medium
has to be defined. Unless otherwise stated, we employed a
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minimal in silico medium consisting of glucose as carbon/
energy source, water, metal ions, nitrogen, phosphate and
sulfur sources, and nicotinate. These components were allow-
ed to enter and leave the cell unrestrained. Exchange fluxes
for compounds present in the in silico medium were
constrained to positive values (i.e., limited to influx). For
metabolites that are capable of leaving the cell (i.e., acetate,
lactate, carbon dioxide, etc.), the exchange fluxes were
constrained to negative values (i.e., limited to efflux).
DEVELOPMENT OF STOICHIOMETRIC
METABOLIC MODEL
Stoichiometric metabolic models can be constructed using
data from different sources. In this work, the development of
the model comprised three distinct steps: (i) exploitation of
genomic databases to construct a first system of mass
balances for the catabolic reactions that lead to the formation
of metabolites (monomers for nucleic acids, proteins, cell
envelope components, and the pool of solutes inside the
cell) and anabolism; (ii) definition of reactions for polymer
and biomass formation and maintenance requirements;
(iii) completion of the model with data from the biochemical
literature and from other database sources, resulting in the
addition of functions not available from the genomic
databases but obviously required by biomass composition
or physiological needs.
For the first step (i), specifically information for the strain
N315 was employed, while for the steps two (ii) and three
(iii), due to the scarcity of experimental data specifically for
N315, data were also taken from other S. aureus strains with
the underlying assumption that the genome-based metabolic
capabilities of the various strains are conserved.
Exploitation of Genome Annotations
The KEGG database (http://www.genome.jp/kegg/) was
taken as starting point for model building, since in this
database the gene annotation of every sequenced strain
is linked to its functions. From this database, the respective
data for S. aureus N315 were downloaded and corrected for
obvious errors (such as the infrequent occurrence of different
names for the same metabolite). As commonly done with
metabolic models, we did not account for the distinction
between a- and b-sugars (Reed et al., 2003). In this first
model reconstruction step, information about reversibility or
irreversibility of reactions was also taken from the KEGG
database using its reaction network maps that represent
several metabolic subsystems. Where identical reactions
were included in several maps but with different directions,
the reversible case was chosen for our model.
To further complement the KEGG reaction network, we
used the TIGR database (http://www.tigr.org). Being based
on the same sequence data, this database runs a different
annotation methodology. There is a large overlap between
these two databases. Metabolic functions additionally
identified by the TIGR annotation (on the basis of completely
assigned EC numbers) were added to our model.
To link the reconstructed intracellular metabolism with the
external environment, analogously to the reactions of the
intracellular metabolism, the information on transporters
were taken from the KEGG as well as from the TIGR
database and supplemented with the corresponding reactions
from the Transport Classification Database TC-DB (http://
tcdb.ucsd.edu).
Due to the advent of the genomic sciences and the
accompanying development of powerful bioinformatics
tools and databases, a large part of the metabolic model can
be reconstructed from gene annotations. However, today’s
data quality and the limited inter-database compatibility are
not sufficient to establish a metabolic model by exclusively
using genomic annotation databases such as KEGG or TIGR.
Large portions of the network, whose presence is demanded
from the biochemical literature or by simple logic are
frequently absent from the sequence annotations (Iliopoulos
et al., 2000). Therefore, a substantial part of the model
building is the manual reconstruction of reactions from
literature, especially in genome regions where limited
homology on amino acid sequence level makes gene function
assignment difficult. Two examples of this are given in the
Results section.
Definition of Biomass Constituting Equations
and Energy Requirements
For any genome-scale metabolic model, a set of biomass
constituting reactions has to be formulated. This set consists
of reactions converting specific metabolites (monomers) into
polymers (including a formal reaction considering the pool
solutes) and a final reaction converting these polymers into
biomass. In our model, the five polymer categories DNA,
RNA, proteins, lipids, and cell wall plus the pool of solutes
were used. According to their experimentally determin-
ed weight fractions in the cellular biomass, these polymers
were then joined together into a final biomass constituting
reaction. ATP consumption for synthesis of RNA, DNA, and
proteins also had to be taken into account. As there is no
specific information available for the energy requirements for
S. aureus, values forE. coliwere used (Ingraham et al., 1983).
No data on biomass composition were available specifi-
cally for strain N315. Thus, literature data originating from a
variety of S. aureus strains had to be employed assuming
similarity between the S. aureus in general and the strain
N315. However, data on the strains’ biomass composition
were obtained under a variety of growth conditions using a
large number of different (typically complex) media. As the
biomass composition depends on medium composition and
growth condition, the available data sets were not coherent.
Through the vast amount of available data (see supple-
mentary information), however, it was possible to derive a
representative average biomass composition of a S. aureus
strain (cf. Table I). As it has also been shown that FBA results
are not very sensitive to variation in biomass composition
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(Pramanik and Keasling, 1998), this averaged biomass
composition was used for all our simulations.
DNA/RNA
The ratio of the nucleic acids in the DNA was derived from
the G/C-content according to the genome sequence (Kuroda
et al., 2001). The RNA nucleic acid composition was also
determined from the genome’s G/C-content assuming that
the ratios of G to C and A to U are unity.
Proteins
For the protein assembly reaction, the average amino acid
composition was taken from a genomic sequence-based
analysis (http://www.pasteur.fr/tekaia/aafreq_GENE.html).
Lipids
The most prominent lipids occurring in S. aureus are
phospholipids, glycolipids, and apolar lipids (Wilkinson,
1997). The phospholipids are phosphatidyl glycerol, cardi-
olipin, and lysyl-phosphatidyl glycerol (Hugo and Davidson,
1973; Koch et al., 1984; O’Leary and Wilkinson, 1988;
White and Frerman, 1967). There are three glycolipids
reported: monoglycosyldiacyl glycerol, diglycosyldiacyl
glycerol, and lipoteichoic acid (Hugo and Davidson, 1973;
White and Frerman, 1967). The major apolar lipid is
menaquinone (White and Frerman, 1967). Furthermore,
there is evidence on the presence of considerable amounts of
1,2-diacylglycerol (Koch et al., 1984).
For acylglycerol-based compounds such as phospholipids,
glycolipids, and 1,2-diacylglycerol, an average fatty acid
chain length of 16 was calculated from experimental data and
an unsaturation of the fatty acids was neglected since it was
shown that only less than 5% of the chains have a C-C-double
bond (Gutberlet et al., 2000; Hugo and Davidson, 1973;
O’Leary and Wilkinson, 1988; Ward and Perkins, 1968;
Weerkamp et al., 1978).
Table I. Metabolites considered to be required for biomass generation in
S. aureus.





















ATP (polymerization energy) 39.94





ATP (polymerization energy) 4.39





ATP (polymerization energy) 1.25









Cell wall (0.24 g cell wall/g CDW) mmol/g cell wall
Crosslinked peptidoglycan 0.363
Teichoic acid 0.019

































Note: An average chain length of the fatty acids of 16 was used as sole
representative for all acyl-chains based lipids.
References for the biomass composition can be found with the
supplementary material.
HEINEMANN ET AL.: GENOME-SCALE METABOLIC NETWORK OF S: AUREUS 853
Cell Wall Constituents
The cell wall constitutents of S. aureus include murein
(Tomasz, 2000; Weidel and Pelzer, 1964), teichoic acids
(Baddiley, 1989), and wall-associated surface proteins (Perry
et al., 2002). The latter have already been considered in the
protein section. The lipoteichoic acids, that is teichoic acids
attached to the membrane lipids, were included in the lipid
fraction as they were determined experimentally as a part of
this fraction (Koch et al., 1984). They are synthesized via a
different pathway than wall teichoic acid and differ
structurally, too (cf. Fig. 1). The wall teichoic acids, linked
to peptidoglycan, and peptidoglycan itself, constitute the
‘‘polymer’’ cell wall.
Pool of Solutes
The pool of solutes includes mainly free amino acids
(Graham and Wilkinson, 1992; Hancock, 1960; Miller
et al., 1991; Tynecka, 1968) and metal ions (Christian and
Waltho, 1964; Graham and Wilkinson, 1992) with potassium
as the predominating ion (Wilkinson, 1997) and carbohy-
drates expressed in glucose equivalents (Miller et al., 1991).
Intracellular concentrations of ATP were taken from the
literature (Vinnikov, 1988), while concentration data for the
remaining pool components (acetyl-CoA, succinyl-CoA,
CoA, FAD, NAD(H), NADP(H)) were taken from E. coli as
they were unavailable for S. aureus (Pramanik and Keasling,
1997; Reed et al., 2003). It is important to note that when a
medium with high osmolarity is employed, glycine betaine
should be added to the pool of solutes, since it is known that
S. aureus uses this compound as pool component in high
amounts for osmoregulation (Graham and Wilkinson, 1992;
Miller et al., 1991).
Biomass Synthesis and
Maintenance Requirements
The above-mentioned polymers are combined into a single
reaction leading to the formation of biomass. The weight
fraction of each polymer was determined based on a number
of different literature sources (Christian and Waltho, 1964;
Hugo and Davidson, 1973; Wilkinson, 1997; Wiltshire and
Foster, 2001).
Not all consumed substrate is used for synthesis of new
biomass and energy production, but some effort is also
essential to maintain the cell’s integrity. In our model, all
maintenance efforts are ‘‘paid’’ for with ATP as energy
currency, which is in agreement with the current practice
in the field (Varma et al., 1993). The ATP maintenance
requirements are typically divided into a growth-associated
and non-growth associated part (Chen, 1964; Tempest and
Neijssel, 1984). The growth-associated portion is normally
considered in the overall biomass equation by an additional
conversion of ATP and water into ADP and orthophosphate.
For the non-growth associated maintenance requirements, an
ATP drain flux is defined constantly removing ATP at a fixed
rate.
The respective values for growth-associated and non-
growth associated ATP maintenance requirements are
normally determined experimentally. Knowing the stoichio-
metry of ATP production and by measuring substrate uptake
rates at varying growth rates, both parameters can be deter-
mined (Stephanopoulos et al., 1998). To the best of our
knowledge, such data are not available for staphylococci.
Experimentally determined maintenance parameters for dif-
ferent organisms show that values of 40 mmol ATP/(g cell dry
weight)/h and 5 mmol ATP/(g cell dry weight) for growth-
associated and non-growth associated maintenance require-
ment are reasonable assumptions, corresponding to an ATP
consumption of about 70 mmol ATP/(g cell dry weight)/h
(Stephanopoulos et al., 1998).
Completion of the Model With Data
From Various Sources
Network gaps remaining after exploitation of genomic
databases were closed with reactions derived from a number
of different sources. Missing reactions in pathways leading to
metabolites for polymers were identified by the use of linear
programming methods, in which metabolite production was
maximized. For the generation of hypotheses on the missing
of certain metabolic functions, reactions from the set of
KEGG reference pathways were systematically added and it
was checked whether the consequent synthesis of the
respective metabolite was possible. None of the reactions
identified to be able to fill certain network gaps could be
inferred from the KEGG genome annotations of any of the
other available S. aureus genome sequences. Thus, the iden-
tified reactions were screened against putatively assigned
enzymes from KEGG and TIGR, which had not been
included in the model until then. The SEED-WIT2 database
(http://wit.mcs.anl.gov/WIT2/) supported comparative anal-
ysis of so far missing functions.
To the largest extent, however, biochemical data from
literature were used to complete the model by adding
enzymes and reactions specifically occurring in S. aureus
strains. In addition to this, additional and so far biochemi-
cally not yet identified reactions had to be inserted in order to
allow for an in silico representation of in vivo observed
physiological behavior. In this context, especially transpor-
ters were added.
Finally, the preliminary set of reaction directions, taken
from the KEGG database, had to be carefully revised, as the
initial set of suggested reaction directions allowed certain
cycle fluxes, which produced ATP without net conversion of
any other metabolite or permitted an artificial transhydro-
genation by converting NADH into NADPH. We changed 30
so far reversible to irreversible reactions in order to avoid
these thermodynamically infeasible flux states or the arti-
ficial transhydrogenation cycles.
Charge and elementally balancing of the reaction network
was omitted as the therefore required additional efforts
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would not have provided a proportional enhancement of
results.
The complete model (including the sources or references
for every reaction including gene names) is available for
download from the supplementary files.
RESULTS
Model Characteristics
In the following, general properties of the reconstructed
network are presented in order to allow for an appraisal of the
completeness of the metabolic model.
The in silico metabolic genotype of S. aureus enables
774 metabolic processes (682 internal processes and 92
transport processes) that influence 712 metabolites. There are
604 enzymes involved, of which 551 have ORF assignments
in the sequence annotations of either KEGG (including the
database’s section of only putatively assigned functions),
TIGR, SEED-WIT2, or the primary annotation (Kuroda et al.,
2001), while the remaining 48 enzymes have not
been assigned to genes but were added to the model due
to biochemical evidence or physiological considerations
(Tables II and III). Table II provides a quantitative summary
of the sources of the metabolic processes comprising internal,
transport, biomass-constituting and maintenance as well as
spontaneous chemical reactions.
The genome sequence of S. aureus N315 is known to have
a length of 2,813,641 base pairs with an estimated 2595
protein-coding regions (Kuroda et al., 2001). Thus, our
metabolic model covers approximately 23% of all ORFs,
assuming that every added and not yet assigned enzymatic
function is encoded in a single gene. In accordance with the
recently proposed nomenclature for in silico metabolic
models (Reed et al., 2003), the model is termed iMH551,
where 551 represents the number of genes involved in the
model with a so far known locus in the genome.
A total of 248 metabolites (approx. 35% of all metabolites)
were found to be involved in only one reaction. In other
words, they were only consumed or only produced, but not
both. Reasons for this could be that connecting reactions
were not yet identified, proteins may have been assigned a
wrong function, or S. aureus N315 has lost specific functions
through evolution. Part of this relatively large portion is
likely to be a result of the still incomplete genome annotation.
The core model without dead-end pathways comprises 549
reactions with 410 metabolites. By addition of 11 auxiliary
reactions (i.e., the biomass constituting and maintenance
reactions) and the corresponding eight auxiliary metabolites
(including the polymers), the model was completed in terms
of biomass assembly and ATP maintenance requirements.
Reconstruction of Pathways to
Cell Envelope Constituents
The S. aureus cell wall is known to be important in the context
of antibiotic resistance (Kuroda et al., 2003; Pechous et al.,
2004). Furthermore, as metabolic alterations affecting the
cell wall structures have been described in this context (Cui
et al., 2000), this motivated us to put a special focus on this
part of the metabolic network.
Reconstructing cell wall and cell membrane metabolism
in particular was strongly hampered by incomplete or even
completely missing pathway assignments from genomic
databases. In this respect it is important to note that such
homology approaches strongly depend on the degree of
enzyme and pathway conservation and might not be useful to
describe specialized metabolic pathways of a particular
strain. Looking at Gram-positive bacteria, pathway varia-
bility is particularly obvious in the context of cell wall
composition, for example the composition of the lipoteichoic
and wall-teichoic acids differs with the genus (Neuhaus and
Baddiley, 2003; Reusch, 1984; Sutcliffe and Shaw, 1991).
Thus, the reconstruction of S. aureus metabolic pathways
leading to these cell wall residues was mainly established
using biochemical literature and not with the aid of genomic
databases. On the other hand, pathways leading to pepti-
doglycan precursors, which are rather well conserved within
Gram-positives (Schleifer and Kandler, 1972), could be
readily reconstructed from genomic databases.
By including information from an additional genomic
database (SEED-WIT2) as well as by adding functions
required by the cell envelope’s composition, it was possible
to develop an overall metabolic picture for the main cell
envelope constituents (Fig. 1). Incorporations of additional
functions included (i) a hypothetical enzymatic step in place
Table II. Sources of in silico metabolic processes.
Total metabolic processes 774
Enzymatic and transport reactions 756




Primary annotation (Kuroda et al., 2001) 8




Spontaneous chemical reactions and transport phenomena 7
Biomass constituting and ATP maintenance reactions 11
Table III. Distribution of reactions of S. aureus with currently no ORF
assignment that were added during the reconstruction process.
Metabolism No. of reactions
Amino acid metabolism 1
Carbohydrate metabolism 7
Energy metabolism 6
Glycan biosynthesis and metabolism 11
Lipid metabolism 16
Membrane transport 3
Metabolism of cofactors and vitamins 3
Nucleotide metabolism 1
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of the still unknown enzymatic machinery required for wall-
teichoic acid attachment to glycan strands (Navarre and
Schneewind, 1999) and (ii) another hypothetical enzymatic
step to include wall-teichoic acid glycosylation (Harrington
and Baddiley, 1985; Neuhaus and Baddiley, 2003).
The quality of this part of our model was confirmed by
flux balance considerations. Predictions of flux distributions
in the pathways to cell envelope constituents under aerobic
conditions with a complex medium containing glucose as
the main carbon source were in good agreement with ex-
perimental results. For example, we calculated a 94%
incorporation of the glycerophosphate moieties of phospha-
tidylglycerol into lipoteichoic acid polymers, whereas 90%
were described in pulse-chase experiments. Furthermore, we
predicted that 8% of 1,2-diacylglycerol are used for the
synthesis of glycolipids and the lipid anchor of lipoteichoic
acids in comparison to the experimentally determined 10%
(Koch et al., 1984).
Overall, with the model we can present an expanded
view of the S. aureus cell envelope metabolism linked to the
entire cellular metabolism. This is in stark contrast to
common attempts focused on localized aspects of distinct
cell envelope structures (Navarre and Schneewind, 1999;
Neuhaus and Baddiley, 2003).
Reconstruction of the Respiratory Chain
As S. aureus is capable of growing aerobically, a fully
functional respiratory chain, including membrane-associated
dehydrogenases, quinone electron transfer, and ATPase had
to be reconstructed (Fig. 2). The KEGG sequence annota-
tion of S. aureus N315 identified several genes encoding
respiratory chain dehydrogenases. These dehydrogenases
oxidize NADH, L-lactate, succinate, glycerol 3-phosphate,
(S)-malate, and formate. In most cases, however, we were
unable to identify the according electron acceptors from
the KEGG sequence annotation. Thus, these reactions were
carefully revised using data from biochemical literature
(Kubak and Yotis, 1981; McNamara and Proctor, 2000;
Sehnalova and Dadak, 1976; Tynecka and Malm, 1996;
Tynecka et al., 1999; Wilkinson, 1997). As menaquinone is
known to be the only quinone in S. aureus (McNamara and
Proctor, 2000 Tynecka et al., 1999; Wilkinson, 1997), the
ubiquinone dependency of the NADH dehydrogenase, erro-
neously identified by the KEGG annotation, was substituted
by a menaquinone dependency (NDH I) (Tynecka et al.,
1999). From the biochemical literature, the list of sequence
derived primary electron donors was further supplemented
by a menaquinone-dependent FADH2 dehydrogenase
(McNamara and Proctor, 2000; Wilkinson, 1997) and a
lactate dehydrogenase with the same electron acceptor
(Tynecka et al., 1999).
Electron transfer to the terminal electron acceptor is
mediated by two terminal oxidases (ba3(a602)- and bo(b556)-
type) that use b-type cytochromes as interim electron carriers
(Tynecka et al., 1999). They are collapsed into one step in
the model and also in Fig. 2. According to studies carried
out with S. aureus 17810R, the NADH dehydrogenase and
the cytochrome b oxidase are translocating protons across
the membrane to establish the proton motive force (PMF)
(Tynecka et al., 1999). As the details of the molecular
mechanisms of the two proton-translocating enzymes are not
available, we assumed that in both cases two protons are
translocated.
The efficiency of the ATPase in S. aureus (F0F1) in using
the PMF to generate ATP was calculated from a literature-
derived experimentally determined PMF (Kashket, 1981).
According to the chemiosmotic theory, the Hþ/ATP stoi-
chiometry was calculated from the comparison of the PMF
and the phosphorylation potential. Applying experimental
data on ATP, ADP, and Pi concentrations for growing
S. aureus cells (Christian and Waltho, 1964; Tynecka et al.,
1999) and on Gibbs free energy of formation of these
compounds under physiological conditions (Alberty, 2000),
Menaquinol
Cytochrome b
O 2H O2 2
NADH FADH2
Lactate SuccinateGlycerol 3-phosphateMalate Formate
H+(extracellular)
2.4 H+
2 H+ ADP + Pi






NO NO3 2- -
red
2 H+
Figure 2. Scheme of the reconstructed respiratory chain. Solid lines represent enzymatic reactions, whereas broken lines denote proton translocation
processes. Only the reduced forms of the metabolites are given in the figure.
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it was calculated that 2.4 protons have to be transported
across the membrane to synthesize one molecule of ATP. The
fact that this thermodynamically determined stoichiometry is
a non-integer number is in agreement with the literature on
other microorganisms, for example E. coli (Jiang et al.,
2001). It results from the fact that the ratio of c subunits in the
Hþ transporting F0 rotary motor (which is still unknown for
the S. aureusATPase) and the three ATP molecules produced
per complete rotary movement of the a3b3 hexamer of the F1
complex is not necessarily an integer number. E.coli, for
example, has ten c subunits, which consequently lead to a
Hþ/ATP stoichiometry of 3.3 (Jiang et al., 2001). In sum-
mary, with the values we have assigned for the proton
translocation in the respiratory chain and the one determined
for the Hþ/ATP stoichiometry, approximately 1.7 molecules
of ATP are produced per molecule of NADH (with NADH-
linked substrates), which is in reasonable agreement with the
generally assumed ratio of 2 for S. aureus (Wilkinson, 1997)
and with the only known experimental S. aureus P/O ratio of
1.3 determined for glutamate as a substrate (Tynecka et al.,
1999).
Under anaerobic conditions, S. aureus is able to grow by
fermentation of a carbohydrate carbon source to lactic acid or
by anaerobic respiration by utilizing nitrate as the terminal
electron acceptor (Burke and Lascelles, 1975). In the latter
case, cytochrome-b (Burke et al., 1981; Burke and Lascelles,
1979; Lascelles and Burke, 1978) and menaquinone (Sasar-
man et al., 1974) take part in the electron transport chain and
we assumed that the nitrate reductase is not involved in
proton translocation.
Prediction of Phenotype Characteristics
With the reconstructed metabolic network, it should now be
possible to predict certain phenotypic characteristics using
the FBA approach. We used maximization of bacterial
biomass production as objective function for FBA, as it has
been shown for E. coli that the cell’s regulatory machinery
indeed controls the metabolic fluxes to achieve maximal
biomass per consumed substrate (Burgard and Maranas,
2003), and fixed a substrate uptake rate. Then FBA allows
calculating the value of all metabolic fluxes. These represent
in principle the enzymatic reaction rates at the organism’s
optimum flux distribution for biomass production. In this
context, it is important to note that typically alternative
optimal solutions exist for the internal flux distribution
(Mahadevan and Schilling, 2003). In the following, examples
of predicted physiological phenotypes will be presented, for
which it was checked that the general result is not influenced
by flux variability.
Minimal Requirements
S. aureus N315 is capable of synthesizing all amino acids,
since the complete set of genes for the corresponding
biosynthesis pathways has been annotated in the genome
(Kuroda et al., 2001). An auxotrophy for several amino acids,
sometimes observed with staphylococci isolated from their
hosts, is commonly explained by a repression of the cor-
responding pathways. These auxotrophies, however, can be
eliminated by successively reducing the number of amino
acids in the medium (Gladstone, 1937). Accordingly, the in
silico organism has no ‘‘intrinsic’’ auxotrophy for any amino
acid.
With the model, however, an auxotrophy is predicted for
nicotinate for the synthesis of NADH and NADPH. This is in
agreement with the literature, while the described require-
ment of thiamin or biotin is not reproduced by the model
(Gladstone, 1937; Kuroda et al., 2001; Miller and Fung,
1973). This is due to the fact that in our model these two B-
group vitamins, representing prosthetic groups for a number
of proteins, are not considered in the biomass composition.
However, this does not have an impact on the results
presented in the following.
In the model, sulfate, ammonia, and inorganic phosphate
are used as sources of sulfur, nitrogen, and phosphorus,
respectively. Furthermore, the in silico organism requires
magnesium, sodium, and potassium ions due to the fact that
these are included in the pool of solutes. In experiments, these
metal ions are also typically added to the medium (Gladstone,
1937; Miller and Fung, 1973; Wu and Bergdoll, 1971).
Aerobic and Anaerobic Growth
Under anaerobic conditions, S. aureus is able to grow by
fermentation of, for example, glucose to lactate or by
anaerobic respiration with nitrate as terminal electron
acceptor (Blumenthal, 1972; Burke and Lascelles, 1975;
Throup et al., 2001). FBA of fermentative growth on glucose
minimal media shows that the in silico organism is unable to
synthesize nucleic acids and consequently also DNA or
RNA. The calculation suggested that this shortcoming could
be compensated by addition of uracil to the medium. This
behavior has been confirmed experimentally (Burke and
Lascelles, 1975; Garrard and Lascelle, 1968; Kashket, 1981;
Wilkinson, 1997). In the following, uracil is added to the in
silico medium.
The experimentally observed main fermentation product
with S. aureus is lactate. It is generated by the reduction of
pyruvate with the NADH-dependent lactate dehydrogenase,
thereby, recycling NADþ. Under respiratory conditions,
NADH recycling is achieved by the various dehydrogenases
belonging to the respiratory chain. Here, an excellent agree-
ment in terms of by-product formation was found between
the experimental data and the simulation. Figure 3A illus-
trates the major fluxes of S. aureus growing anaerobically on
glucose.
It was shown experimentally that the anaerobic respira-
tion uses the same apparatus as the aerobic respiration
(e.g., menaquinone and cytochrome-b as electron carriers)
(Lascelles, 1979; Lascelles and Burke, 1978; Sasarman et al.,
1974). Also, the model predicts that the flux distribution for
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anaerobic respiration is similar to the one for aerobic res-
piration with the difference that nitrate reductase instead of
cytochrome-b oxidase is used to transfer electrons to the
terminal electron acceptor.
Under aerobic conditions, S. aureus utilizes glycolysis,
pentose phosphate pathway, and TCA cycle to catabolize
glucose (Blumenthal 1972). An excess of this particular
carbon source, however, leads to repression of the TCA cycle
activity and excretion of acetate (Blumenthal, 1972; Somer-
ville et al., 2002, 2003). This behavior, known as ‘‘glucose
effect,’’ cannot be simulated with FBA using growth maxi-
mization as objective function as the secretion of not
completely oxidized carbon will result in a reduction of
biomass yield. This contradicts the given FBA objective
function. In a rich carbon source environment, however,
maximization of biomass yield might be less important
and other objectives may be more favorable for the cell
(e.g., inhibition of competing bacteria in the body). As the
true objective for this glucose effect remains elusive, we
included its manifestation (downregulation of TCA activity)
by constraining fluxes. In this particular case, we constrained
the flux through the acontinate hydratase reaction (encoded
by acnA) for aerobic conditions and glucose excess. Release
of acetate into the medium was then also observed in silico.
An experimental analysis of an acnA mutant supported this
approach: During the exponential growth phase, no signifi-
cant difference in growth rate between the acnA mutant and
the wild-type strain was observed (Somerville et al., 2002),
which is completely in line with the prediction of the adapted
model (although the model predicts an additional glutamate
auxotrophy for the mutant, which would have remained
undetected in the experiment because of complex medium).
Figure 3B illustrates the major fluxes of the wild type
(simulated as acnA mutant) growing with glucose excess.
The presented results demonstrate that the model is cap-
able of reproducing the main characteristics of aerobic and
anaerobic growth as described in the experimental literature.
An exact comparison of yields or growth rates was impos-
sible because in most cases experimental data were obtained
with complex media, of which the exact chemical composi-
tion was unknown. For an exact comparison of yields,
however, the medium composition has to be known, whereas
for a prediction of growth rates also experimentally deter-
mined substrate uptake rates are necessary, which are also not
available from the literature.
Nevertheless, by-product formation as well as the require-
ment of additional medium components is either correctly
predicted with our model using FBA with growth maximiza-
tion as objective function or can be easily accounted for. This
indicates that also for S. aureus this objective function is in
most in vitro cases applicable as it has been shown for E. coli
(Burgard and Maranas 2003).
Small Colony Variants
Having validated our model against the available experi-
mental evidence, we proceeded to analyze a clinically rele-
vant phenotype. Small colony variants (SCV) of S. aureus
have been the focus of several studies because of a close
association between the recovery of SCV and infections
(Kohler et al., 2003; McNamara and Proctor, 2000). SCV
show an alteration in metabolism leading to slow growth. It
has been suggested that this is mainly caused by the inter-
ruption of the electron transport chain (Proctor et al., 1994).
To analyze small colony variants experimentally, hemB
mutants were constructed (Kohler et al., 2003; McNamara
and Proctor, 2000; von Eiff et al., 1997). These mutants lack
the ability to synthesize heme and thus mimic SCV with their
interrupted electron transport chain. As the SCV phenotype is
experimentally rather well defined, we investigated whether
our model could faithfully reproduce the observed behavior
by simply removing the heme-requiring cytochrome-b

































Figure 3. Illustration of major fluxes of S. aureus growing anaerobically on glucose medium without nitrate (A) and growing aerobically on medium with
glucose excess and glutamate (simulated as acnAmutant) (B). Fluxes are given relative to the specific glucose consumption rate. TCA: tricarboxylic acid cycle;
PPP: pentose phosphate pathway.
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When aerobic conditions and a mineral medium with
glucose were assumed for the in silico hemB mutant, we
found an essentially fermentative behavior: lactate excretion
and consequently reduced growth rate. Correctly, the in silico
hemB mutant did not show nitrite accumulation after nitrate
addition as found experimentally (Burke and Lascelles,
1975). As a next step, we added systematically all pro-
teinogenic amino acids, for which S. aureus can provide a
transporter to the nitrate-free medium separately and inves-
tigated their effect on growth rate. According to the model,
glutamate, glutamine, and arginine should lead to an increase
in growth rate because of additional energy production.
Isoleucine, leucine, valine, and lysine should be utilized
directly for polymer synthesis (also leading to a growth rate
increase), whereas glycine and alanine should not be con-
sumed at all. The last effect is a result of the fact that the
transport of these two amino acids into the cell is under these
specific modeling conditions energetically more costly than
the potential gain by avoided biosynthesis.
Looking more detailed at the effect of glutamate, gluta-
mine, and arginine in the medium, the model predicted that
arginine would be used for protein synthesis and ATP pro-
duction (via the breakdown of carbamoyl-phosphate
obtained from citrulline), explaining the effect on growth
rate. Remarkably, this is very much in line with protein
expression studies that showed an increase in the level of the
enzymes of the arginine deiminase pathway together with the
level of glycolytic enzymes in a hemB mutant during
anaerobiosis (Kohler et al., 2003). From the experimental
study, it was postulated that arginine was depleted to finally
produce ATP (Kohler et al., 2003).
Furthermore, the model predicted that glutamate and
glutamine would increase biomass yields by ATP production.
In these cases, acetate is excreted via pyruvate oxidase and
acetate kinase with concomitant formation of ATP. However,
this acetate excretion is not observed experimentally (Kohler
et al., 2003), providing a strong indication that pyruvate
oxidase and acetate kinase are not synthesized in the hemB
mutant. As such a mutant exists under ‘‘quasi’’-fermentative
conditions, the lack of synthesis of pyruvate oxidase and
acetate kinase should be in line with its regulatory pattern, as
these two enzymes are not needed under fermentation condi-
tions. Thus, it can be hypothesized that despite the presence
of oxygen, only fermentative pathways are activated in the
hemB mutant.
Effect of In Silico Gene Deletions
A gene product that is essential for bacterial growth is a
potential target for antibacterial chemotherapy. However,
experimental methods for determining whether a gene is
essential for growth always involve laborious experiments in
order to construct a desired genotype. Even though techno-
logies such as in vitro expression technology will remain
invaluable tools to identify elements for example of the
bacterial infection process (Angelichio and Camilli, 2002), a
metabolic model might be a much more economic way to
generate a set of rational hypotheses regarding the essenti-
ality of particular genes under a large set of environmental
circumstances. FBA has proven to be a versatile tool to
determine the effects of variations in the metabolic genotype
(Price et al., 2003). Such in silico screenings for gene deletion
effects can be performed within a few minutes, including
variations in media and growth conditions.
We have carried out such an analysis for the internal
reactions of the core metabolic model of S. aureus (without
the dead-end pathways, see above) using aerobic growth
conditions on complex medium as a test case. The employed
medium, designed according to a Staphylococcus medium
from Difco Laboratories (Bacto Staphylococcus), contained
glucose, lactose, and mannitol as carbon sources, all amino
acids for which transporters exist, nicotinate and choline as
well as the typically employed nitrogen, sulfur, phosphorus
sources (NH3, sulfate, orthophosphate), and metal ions
(Zn2þ, Kþ, Naþ, Mg2þ).
The flux balance analysis revealed that the removal of 158
reactions from the model prevented growth. Table IV gives an
overview about the distribution of those reactions whose
elimination is incompatible with growth.
The number of predicted essential reactions in relation to
the total number of reactions in each sub-metabolism allows
classifying the sub-metabolisms into flexible or rigid parts. It
is obvious that especially the glycan, lipid, cofactor, and
vitamin metabolisms are quite rigid and deletions can hardly
be compensated by means of alternative pathways and are
potential targets for antibiotic action. A complete list of the




Total no. of reactions
in sub-metabolism Percentage [%] Classification
Metabolism of proteinogenic amino acids 33 137 24 Flexible
Biodegradation of xenobiotics 0 6 0 Not used for growth
Carbohydrate metabolism 19 97 20 Flexible
Energy metabolism 3 16 19 Flexible
Glycan biosynthesis and metabolism 18 18 100 Rigid
Lipid metabolism 32 54 59 Rigid
Metabolism of cofactors and vitamins 29 60 48 Rigid
Metabolism of non-proteinogenic amino acids 2 8 25 Flexible
Nucleotide metabolism 20 87 23 Flexible
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computational gene deletion results is available in the sup-
plementary files.
The results of our gene deletion study can be compared
with experimental data on the effect of metabolic gene
deletion from the literature (Jana et al., 2000; Ji et al., 2001;
Wilding et al., 2000). From these experimental studies, only
those genes were considered for comparison for which an
according model reaction could unambiguously be identi-
fied. The results of the comparison are provided in Table V.
In this table, the experimental data are categorized in lethal
and defective, indicating that the gene deletion has resulted
in an unviable cell or in a growth-defective phenotype,
respectively. For the computational analysis, the phenotype
categories are lethal, yield reduction (corresponding to
defective), and no difference (indicating that in silico there
is no difference between the wild type and the mutant
phenotype in terms of growth rate).
Inspection of Table V reveals that all the lethal gene dele-
tions identified experimentally were correctly predicted by
our model. This is a strong indication that the experimentally
observed lethality of these particular gene deletions has
indeed metabolic reasons. Furthermore, the experimentally
observed growth-defective phenotype of three more genes
was correctly predicted. Another three genes, for which the
model did not identify any effect on growth rate, experimen-
tally showed a growth-defective phenotype. This could
indicate that an alternative pathway, chosen in the simulation
to circumvent the gene deletion, in fact could not be
upregulated to a sufficient level in vivo. Finally, three genes
were found to be growth-defective in the experiment whose
deletion was predicted lethal in the computational analysis. It
turned out that the latter false negatives all encode reactions
in the purine metabolism, indicating that this sub-metabolism
has to be incomplete in the model. In fact, during the model
construction process the purine metabolism required exten-
sive addition of reactions from the KEGG pool of putatively
assigned genes or other genomic databases such as SEED or
TIGR. This supports the view that purine metabolism genes
are poorly conserved and that a number of alternative routes
might still exist. Future model extension efforts, therefore,
should place a special focus on this area.
In summary, the gene deletion analysis provided an
extensive list of metabolic genes that are predicted essential
since there is no alternative route available to compensate the
deletion. Obviously, there are certain limits to the predictive
power of this approach, most prominently because a sub-
stantial part of the genome has not been annotated so far and
thus some of the reactions identified as essential in the
currently available model might not be so in reality. On the
other hand, we have to point out that in fact a larger number of
metabolic genes could be essential for growth. As regula-
tion aspects (such as for example the regulation-related
auxotrophy for certain amino acids (Gladstone, 1937)) are
not considered in this metabolic model, it is impossible to
identify cases in which a pathway proposed in silico to
circumvent a specific gene deletion in reality cannot be













































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































HEINEMANN ET AL.: GENOME-SCALE METABOLIC NETWORK OF S: AUREUS 861
induced. Nevertheless, applying this large-scale gene dele-
tion study, rational hypotheses for drug targets can easily be
generated. The enzymes for glycan biosynthesis and lipid
metabolism seem to be a promising target as these sub-
metabolisms are quite inflexible.
CONCLUSIONS
A validated metabolic network of S. aureus N315, which
represents an extensive compendium on S. aureus metabo-
lism, was able to predict a number of different metabolic
phenotypes and could be used to predict the effects of gene
deletions on growth behavior. We hope that the model will
be a useful guiding tool for potential future experiments
to elucidate the interrelationship of bacterial metabolism
and resistance. Furthermore, combining this stoichiometric
model with transcriptomic and proteomic data in the future
should allow a new quality in the analysis of clinically
relevant organisms and a more rationalized system-level
search for novel drug targets.
NOTE
During the review process, we became aware of another most
recently published metabolic model for S. aureus N315
(Becker and Palsson, 2005).
The authors are indebted to the invaluable help of Brigitte Berger-
Ba¨chi and her group, Giorgia Valsesia, and Greg Cook.
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